/NGMDF
NGMDF Stock - NuGen Medical Devices Inc.
Healthcare|Medical - DevicesOTC
$0.03+0.00%
+$0.00 (+0.00%) • Jan 12
43
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.4
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NGMDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.03
TARGET (TP)$0.03
STOP LOSS$0.02
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.05
52W High$0.07
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.01M | $331,403 | $152,358 | $137,648 | $47,295 |
| Gross Profit | $521,937 | $164,841 | $-553,231 | $92,224 | $34,385 |
| Gross Margin | 51.7% | 49.7% | -363.1% | 67.0% | 72.7% |
| Operating Income | $-5,157,464 | $-8,048,054 | $-4,794,040 | $-7,671,297 | $-2,611,180 |
| Net Income | $-5,225,783 | $-9,362,217 | $-5,577,926 | $-7,107,082 | $-3,670,402 |
| Net Margin | -517.5% | -2825.0% | -3661.1% | -5163.2% | -7760.7% |
| EPS | $-0.02 | $-0.06 | $-0.06 | $-0.10 | $-0.14 |
Company Overview
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NGMDFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 27, 2026 | — | — | — | — |
Q4 2025 | Dec 1, 2025 | — | $-0.01 | — | — |
Q3 2025 | Aug 27, 2025 | — | $-0.01 | — | — |
Q2 2025 | Apr 28, 2025 | — | $0.00 | — | — |
Q4 2024 | Dec 31, 2024 | — | $0.00 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 30, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.01 | — | — |
Q4 2023 | Nov 29, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 29, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 30, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.04 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NGMDF
What is NGMDF's current stock price?
NuGen Medical Devices Inc. (NGMDF) is currently trading at $0.03 per share. The stock has moved +0.00% today.
What is the analyst price target for NGMDF?
No analyst price targets are currently available for this stock.
What sector is NuGen Medical Devices Inc. in?
NuGen Medical Devices Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is NGMDF's market cap?
NuGen Medical Devices Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does NGMDF pay dividends?
No, NuGen Medical Devices Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADMT
ADM Tronics Unlimited, Inc.
$0.11
Mkt Cap: $0.0B
ANPCF
Cellbxhealth PLC
$0.03
Mkt Cap: $0.0B
CMHSF
Comprehensive Healthcare Systems, Inc.
$0.45
Mkt Cap: $0.0B
INTI
Inhibitor Therapeutics, Inc.
$0.08
Mkt Cap: $0.0B
LIANY
LianBio
$0.10
Mkt Cap: $0.0B
NSVGF
Nass Valley Gateway Ltd.
$0.01
Mkt Cap: $0.0B
ODYY
Odyssey Health, Inc.
$0.07
Mkt Cap: $0.0B
PMEDF
Predictmedix Inc.
$0.04
Mkt Cap: $0.0B
PMSNF
Proteome Sciences plc
$0.03
Mkt Cap: $0.0B
PNPL
Pineapple, Inc.
$0.11
Mkt Cap: $0.0B
Explore stocks similar to NGMDF for comparison